[PDF] Top 20 Original Article KDM4A, KDM4B and KDM4C in non-small cell lung cancer
Has 10000 "Original Article KDM4A, KDM4B and KDM4C in non-small cell lung cancer" found on our website. Below are the top 20 most common "Original Article KDM4A, KDM4B and KDM4C in non-small cell lung cancer".
Original Article KDM4A, KDM4B and KDM4C in non-small cell lung cancer
... ERα, KDM4A appears to activate androgen receptor thus making it putatively important also in prostate cancer tumor growth ...this, KDM4A was found to be overexpressed in prostate carcino- ma ...of ... See full document
7
Original Article Amygdalin-mediated inhibition of non-small cell lung cancer cell invasion in vitro
... the cancer cells to break free from constrains of the surrounding cells, making it easier to penetrate through the basal mem- brane and invade the surrounding ...to cancer pro- gression and metastasis ... See full document
8
Original Article UBE2T silencing inhibited non-small cell lung cancer cell proliferation and invasion by suppressing the wnt/β-catenin signaling pathway
... in cancer progression. However, its role in non-small cell lung cancer (NSCLC) progression is still ...and cell lines. Cell proliferation was detected using MTT ... See full document
7
Original Article Prognostic value of KIF2A and TP53 overexpression in non-small cell lung cancer
... in cell mitosis, migration, and signaling transduction ...the cell cycle progression was inhibited in KIF2A-deficient cells and these cells formed monopolar spin- dles instead of normal bipolar spindles in ... See full document
10
Original Article Downregulation of TMEM176A suppresses cell growth and proliferationin non-small cell lung cancer
... NSCLC cell lines (A549 and 95D) were pur- chased from Cell Bank of the Chinese Academy of Sciences, Shanghai, China and maintained in RPMI-1640 (Hyclone, Biowest) supplement- ed with 10% fetal bovine serum ... See full document
9
Original Article Efficacy and safety of Endostar (recombinant human endostatin hormone) combined with docetaxel as second-or third-line therapy for patients with non-small-cell lung cancer
... [33] Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, ... See full document
10
Original Article Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy
... Glutathione S-transferase P1 (GSTP1) is one of the glutathione S-transferase class members, and is widely expressed in different human tis- sues including lung and liver. It has an impor- tant role in the phase II ... See full document
7
Original Article Vasculogenic mimicry and expression of slug and vimentin correlate with metastasis and prognosis in non-small cell lung cancer
... specimens. These data were compared to patient clinicopathologic characteristics. The positive rate of VM (small vessel, which is like a lumen in NSCLC, the lumen was PAS- positive but CD34-negative). The VM ... See full document
10
Original Article Effect of miR-18a overexpression on the radiosensitivity of non-small cell lung cancer
... of non-small-cell lung caner ...for lung cancer cell radioresistance, A549 cells were treated with different doses of ionizing radiation, following transfection with ... See full document
6
Original Article ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer
... and cell motility (ELMO) pro- teins family which is consists of ELMO1, ELMO2, and ELMO3, widely distribute in mammals and participate in a various of life action including cell migration, cell ... See full document
6
Original Article The association between SLFN5 expression and the prognosis of non-small cell lung cancer
... adjacent non-can- cerous tissue specimens submitted by Outdo Biotech ...of lung adenocar- cinoma without lung transplantation, radiation therapy, adjuvant chemotherapy or immuno- therapy before or ... See full document
8
Original Article Gefitinib and docetaxel for the treatment of non-small cell lung cancer: a meta-analysis
... [15] Kris MG, Natale RB, Herbst RS, Lynch TJ Jr, Prager D, Belani CP, Schiller JH, Kelly K, Spiri- donidis H, Sandler A, Albain KS, Cella D, Wolf MK, Averbuch SD, Ochs JJ and Kay AC. Efficacy of gefitinib, an inhibitor ... See full document
9
Original Article Pemetrexed and cyclophosphamide combination therapy for the treatment of non-small cell lung cancer
... Dose adjustments to new cycles were based on the consideration of the worst toxicity observed during the previous cycle. Treatment interruptions up to 14 days were allowed for recovery from adverse events. Pe- metrexed ... See full document
8
Original Article Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer
... secondary antibody (Envision; Dako, Glostrup, Denmark) for 1 h at room temperature and stained with DAB (3,3- diaminobenzidine). Fin- ally, the sections were counterstained with Mayer’s hematoxylin, dehydrated, and ... See full document
9
Original Article Assoication of XRCC1 gene polymorphisms with risk of non-small cell lung cancer
... in cell death, genetic instability, muta- genesis or cancer ...ing small base lesions in DNA that are the results of oxidation and alkylation damage, and this pathway is correlated with risk of ... See full document
6
Original Article The identification of genes associated with NSCLC prognosis based on an integrated bioinformatics analysis
... “non-small cell lung cancer”, and the can- cer type was non-small cell lung cancer (adenocarcinoma of the lung and squamous cell ... See full document
8
Original Article Increased expression of TUSC3 in non-small cell lung cancer
... in non-small cell lung can- cer (NSCLC) compared to adjacent normal tissue, and its correlation with patients’ clinicopathological ...NSCLC cell lines was assayed by Western ...NSCLC ... See full document
8
Original Article The role of ATP8A1 in non-small cell lung cancer
... NSCLC cell invasion and migration, and now after over a hundred years of hard work, the theory of NSCLC metastasis regulation with multiple factors, multiple mechanisms and multiple genes is gradually been ... See full document
7
Original Article Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer
... In this study, we investigated the distribution of PAX2 and PAX5 in lung cancer tissues. However, our immunohistochemical results showed that the percentage of patients with PAX2 or PAX5 positive cells has ... See full document
8
Original Article FRS2 promotes the progression of non-small cell lung cancer
... Abstract: Lung cancer is one of the leading causes for cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for the majority of all ... See full document
8
Related subjects